# Verastem, Inc.: filings

VSTM · Nasdaq · CIK 1526119 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vstm.md) · [Financials](/companies/vstm/financials.md) · [Filings](/companies/vstm/filings.md) · [Insiders](/companies/vstm/insiders.md)

## Reports and events: 242 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 456, 8-K 150, 3 51, SC 13G/A 47, 10-Q 44, SCHEDULE 13G/A 32, SC 13G 30, 144 18, 424B5 18, DEF 14A 16, S-8 16, 10-K 15, CORRESP 14, SCHEDULE 13G 14, EFFECT 12, UPLOAD 12, CT ORDER 10, S-3 10, 4/A 8, 5 8, SC 13D/A 7, D 6, 424B3 4, PRE 14A 4, SC 13D 4, 424B2 3, DEFA14A 3, S-1/A 3, S-3/A 3, 3/A 2, 8-K/A 2, FWP 2, SEC STAFF LETTER 2, 144/A 1, 305B2 1, 424B4 1, 8-A12B 1, CERTNAS 1, D/A 1, POS AM 1, POSASR 1, S-1 1, S-1MEF 1, S-3ASR 1, S-3MEF 1, SC TO-I 1, SC TO-I/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-14 | 17:21 ET | [8-K](/filings/0001104659-26-115880.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-115880 |
| 2026-10-14 | 06:08 ET | [8-K](/filings/0001104659-26-115687.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-115687 |
| 2026-08-07 | 19:33 ET | [8-K](/filings/0001104659-26-092216.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-092216 |
| 2026-08-06 | 16:29 ET | [8-K](/filings/0001104659-26-092058.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-092058 |
| 2026-08-06 | 16:12 ET | [10-Q](/filings/0001104659-26-092007.md) | Quarterly report, period 2026-06-30 | 0001104659-26-092007 |
| 2026-06-23 | 16:02 ET | [8-K](/filings/0001104659-26-076809.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-076809 |
| 2026-06-17 | 08:52 ET | [8-K](/filings/0001104659-26-074915.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-074915 |
| 2026-05-26 | 08:15 ET | [8-K](/filings/0001104659-26-066026.md) | 5.07 Shareholder vote results | 0001104659-26-066026 |
| 2026-05-07 | 16:11 ET | [8-K](/filings/0001104659-26-057126.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-057126 |
| 2026-05-07 | 16:07 ET | [10-Q](/filings/0001104659-26-057114.md) | Quarterly report, period 2026-03-31 | 0001104659-26-057114 |
| 2026-04-09 | 16:14 ET | [DEF 14A](/filings/0001104659-26-041506.md) | Proxy statement, period 2026-05-21 | 0001104659-26-041506 |
| 2026-03-04 | 16:15 ET | [8-K](/filings/0001104659-26-023462.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-023462 |
| 2026-03-04 | 16:06 ET | [10-K](/filings/0001104659-26-023444.md) | Annual report, period 2025-12-31 | 0001104659-26-023444 |
| 2026-02-04 | 07:30 ET | [8-K](/filings/0001104659-26-010036.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-010036 |
| 2026-01-08 | 16:16 ET | [8-K](/filings/0001104659-26-002135.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-002135 |
| 2025-12-31 | 19:02 ET | [8-K](/filings/0001104659-25-125309.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-125309 |
| 2025-12-19 | 17:21 ET | [8-K](/filings/0001104659-25-123295.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-123295 |
| 2025-11-17 | 07:30 ET | [8-K](/filings/0001104659-25-112946.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-112946 |
| 2025-11-04 | 16:11 ET | [10-Q](/filings/0001104659-25-106279.md) | Quarterly report, period 2025-09-30 | 0001104659-25-106279 |
| 2025-11-04 | 07:30 ET | [8-K](/filings/0001104659-25-105923.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-105923 |
| 2025-10-23 | 16:02 ET | [8-K](/filings/0001104659-25-101817.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-101817 |
| 2025-10-20 | 06:01 ET | [8-K](/filings/0001104659-25-100537.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-100537 |
| 2025-09-08 | 07:01 ET | [8-K](/filings/0001104659-25-088021.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-088021 |
| 2025-08-13 | 17:20 ET | [8-K](/filings/0001104659-25-077659.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-077659 |
| 2025-08-07 | 16:06 ET | [10-Q](/filings/0001558370-25-010757.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010757 |
| 2025-06-02 | 12:01 ET | [8-K](/filings/0001104659-25-055322.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-055322 |
| 2025-06-02 | 09:40 ET | [8-K](/filings/0001104659-25-055286.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-055286 |
| 2025-05-23 | 07:12 ET | [8-K](/filings/0001104659-25-052220.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-052220 |
| 2025-05-13 | 16:04 ET | [10-Q](/filings/0001558370-25-007570.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007570 |
| 2025-05-08 | 16:31 ET | [8-K](/filings/0001104659-25-046175.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-046175 |
| 2025-04-25 | 09:29 ET | [8-K](/filings/0001104659-25-039098.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-039098 |
| 2025-04-08 | 16:10 ET | [DEF 14A](/filings/0001558370-25-004597.md) | Proxy statement, period 2025-05-22 | 0001558370-25-004597 |
| 2025-03-20 | 16:08 ET | [8-K](/filings/0001104659-25-026130.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-026130 |
| 2025-03-20 | 16:01 ET | [10-K](/filings/0001558370-25-003372.md) | Annual report, period 2024-12-31 | 0001558370-25-003372 |
| 2025-01-23 | 07:42 ET | [8-K](/filings/0001104659-25-005460.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-005460 |
| 2025-01-21 | 16:30 ET | [8-K](/filings/0001104659-25-004918.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-004918 |
| 2025-01-13 | 07:36 ET | [8-K](/filings/0001104659-25-002859.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-002859 |
| 2024-11-06 | 16:22 ET | [10-Q](/filings/0001558370-24-014640.md) | Quarterly report, period 2024-09-30 | 0001558370-24-014640 |
| 2024-10-17 | 11:50 ET | [8-K](/filings/0001104659-24-109439.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-109439 |
| 2024-08-08 | 16:10 ET | [10-Q](/filings/0001558370-24-011599.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011599 |
| 2024-07-25 | 08:45 ET | [8-K](/filings/0001104659-24-082526.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-082526 |
| 2024-07-23 | 16:01 ET | [8-K](/filings/0001104659-24-081882.md) | 8.01 Other events | 0001104659-24-081882 |
| 2024-06-26 | 07:00 ET | [8-K](/filings/0001104659-24-074956.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-074956 |
| 2024-05-24 | 07:01 ET | [8-K](/filings/0001104659-24-064919.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-064919 |
| 2024-05-23 | 17:24 ET | [8-K](/filings/0001104659-24-064781.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-064781 |
| 2024-05-09 | 16:08 ET | [10-Q](/filings/0001558370-24-007607.md) | Quarterly report, period 2024-03-31 | 0001558370-24-007607 |
| 2024-04-12 | 16:05 ET | [DEF 14A](/filings/0001558370-24-005017.md) | Proxy statement, period 2024-05-23 | 0001558370-24-005017 |
| 2024-04-09 | 17:10 ET | [8-K](/filings/0001104659-24-045266.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-045266 |
| 2024-03-14 | 16:55 ET | [10-K](/filings/0001558370-24-003250.md) | Annual report, period 2023-12-31 | 0001558370-24-003250 |
| 2024-01-29 | 16:01 ET | [8-K](/filings/0001104659-24-007712.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-007712 |

Page 1 of 5. [Older](/companies/vstm/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 12:42 ET. No prices; not investment advice.